SNN awards €18.000 to investigate the feasibility of eye movements tests in pediatric cerebral palsy
In absence of a shared "golden standard", Dystonic Cerebral Palsy can be difficult to correctly diagnose and distinguish from other forms of Pediatric Movement Disorders.
Eye movements are a very promising biomarker to support the phenotypization of these complex diseases.
Our goal at Reperio Medtech is to develop child-friendly tests that can help in the correct identification of the movement disorder in a completely non-invasive and stress-free manner.
If you would like to learn more, send us an email at email@example.com